Breaking News

Tria Rolls Out FDA-Approved Laser

By Christine Esposito, Associate Editor | January 13, 2014

Age-Defying Laser for home use online now, in stores next month.

Tria Beauty, Inc. has launched its Age-Defying Laser in the United States.  Recently cleared by the FDA for the treatment of multiple signs of facial aging, this newest skincare laser from Tria is clinically proven to treat multiple signs of facial aging as well as comparable dermatologist treatments and delivers superior results compared to traditional at-home anti-aging regimens.

Beginning today, the Age-Defying Laser is available for sale at traibeauty.com for $495 and comes with a free gift including, Age-Defying Priming Cleanser and Finishing Serum, which are specially formulated to prep skin for laser treatments and soothe and hydrate
treated skin.

The Age-Defying Laser will also be launching in February at Barneys, Bloomingdale's and Sephora stores across the country. 

"This new product launch represents a key growth milestone for Tria - our entry into the anti-aging skincare category, the largest and fastest growing segment of prestige beauty.  Continuing to launch transformative skincare products like the Age-Defying Laser and expanding distribution with key partners like Sephora will ensure Tria continues its year-over-year, double-digit growth and further cements our brand's leadership position in the skincare category" stated Nicole Landberg, VP/GM, Americas & Europe, Tria Beauty.

Related End-User Markets:

blog comments powered by Disqus
  • Innovation On Display

    Melissa Meisel, Associate Editor||February 3, 2016
    P&G Beauty Digital Studio showcases new products for 2016

  • Burgeoning Beauty

    Burgeoning Beauty

    Melissa Meisel, Associate Editor||January 4, 2016
    A look at trailblazers for 2016 and beyond.

  • Testing for Sustainable Preservatives

    Adam P. Byrne, William Michael Hart-Cooper, Kaj Johnson, Larry H. Stanker, Dominic W. S. Wong, William J. Orts||January 4, 2016
    A rapid, inexpensive and qualitative protocol for determining microbial growth inhibition.